Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
United States
Cedars-Sinai Medical Center, Los Angeles, California University of Iowa Hospitals and Clinics, Iowa City, Iowa Dana-Farber Cancer Institute, Boston, Massachusetts University of Michigan, Ann Arbor, Michigan Memorial Sloan Kettering Cancer Center, New York, New York Children's Hospital of Philadelphia, Philadelphia, Pennsylvania